Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-4729 Injection in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 study of HRS-4729 injection in healthy subjects to evaluate safety, tolerability, pharmacokinetics and pharmacodynamics; the trial is currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• HRS-4729

Snippet

Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. | Conditions: Overweight or Obesity | Phase 1 | Status: RECRUITING